NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

過敏性結膜炎(AC):流行病學的預測(2027年)

Allergic Conjunctivitis (AC) - Epidemiology Forecast to 2028

出版商 DelveInsight Business Research LLP 商品編碼 524438
出版日期 按訂單生產 內容資訊 英文 50 Pages
商品交期: 2-10個工作天內
價格
過敏性結膜炎(AC):流行病學的預測(2027年) Allergic Conjunctivitis (AC) - Epidemiology Forecast to 2028
出版日期: 按訂單生產內容資訊: 英文 50 Pages
簡介

過敏性結膜炎(AC)的診斷患者數,2016年推定為6,494萬5,428人。

本報告提供過敏性結膜炎的相關調查,總括性彙整疾病概要,患者背景,主要7個國家(美國,英國,德國,法國,義大利,西班牙,日本)的患病數趨勢,流行病學的預測(過去2年·今後10年份),目前未滿足需求,今後市場機會等資訊。

目錄

第1章 重要的洞察

第2章 過敏性結膜炎:疾病的背景和概要

  • 簡介
  • 過敏性結膜炎的分類
  • 原因
  • 危險因素
  • 症狀
  • 病理生理學
  • 診斷

第3章 流行病學和患者人口

第4章 主要觀察

  • 人口與預測參數
  • 主要7個國家過敏性結膜炎的整體診斷患者數

第5章 過敏性結膜炎的流行病學

  • 美國
    • 過敏性結膜炎的患病數
    • 過敏性結膜炎的患病數:各類型
  • 歐盟5國
    • 德國
      • 過敏性結膜炎的患病數
      • 過敏性結膜炎的患病數:各類型
    • 法國
      • 過敏性結膜炎的患病數
      • 過敏性結膜炎的患病數:各類型
    • 義大利
      • 過敏性結膜炎的患病數
      • 過敏性結膜炎的患病數:各類型
    • 西班牙
      • 過敏性結膜炎的患病數
      • 過敏性結膜炎的患病數:各類型
    • 英國
      • 過敏性結膜炎的患病數
      • 過敏性結膜炎的患病數:各類型
  • 日本
    • 過敏性結膜炎的患病數
    • 過敏性結膜炎的患病數:各類型

第6章 未滿足需求

第7章 附錄

第8章 調查方法

第9章 DelveInsight的服務內容

第10章 免責聲明

第11章 關於DelveInsight

目錄
Product Code: DIEI0022

DelveInsight's 'Allergic Conjunctivitis (AC) - Epidemiology Forecast to 2028' report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Allergic Conjunctivitis in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

Geography Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain and the United Kingdom)
  • Japan

Study Period: 2016-2028

Allergic Conjunctivitis Epidemiology

The Allergic Conjunctivitis (AC) epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. The epidemiology data for Allergic Conjunctivitis are studied through all possible division to give a better understanding about the Disease scenario in 7MM. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Allergic Conjunctivitis Epidemiology Segmentation

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (total prevalent cases, diagnosed prevalent cases and sub-type specific prevalence) scenario of Allergic Conjunctivitis (AC) in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2016-2028.

The DelveInsight report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

According to DelveInsight, the total number of diagnosed prevalent population of Allergic Conjunctivitis (AC) was found to be 64,945,428, in the year 2016.

Report Scope

  • The report covers detailed overview of Allergic Conjunctivitis explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The report provides the insight about the historical and forecasted patient pool of Allergic Conjunctivitis in 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
  • The Report assesses the disease risk and burden and highlights the unmet needs of the disease
  • The Report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report provides the segmentation of the disease epidemiology by sub-type i.e., Acute & Chronic Allergic Conjunctivitis in 7MM

Key strengths

  • 10 Year Forecast of Allergic Conjunctivitis epidemiology
  • 7MM Coverage
  • Total Prevalent Cases of AC
  • Prevalent Cases according to segmentation: Subtype-specific prevalence i.e., Acute & Chronic AC
  • Diagnosed cases of AC

Key assessments

  • Patient Segmentation
  • Disease Risk & Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

Table of Contents

1. Key Insights

2. Disease Background and Overview: Allergic Conjunctivitis (AC)

  • 2.1. Introduction
  • 2.2. Classification of Allergic Conjunctivitis
  • 2.3. Causes
  • 2.4. Risk factors
  • 2.5. Symptoms
  • 2.6. Pathophysiology
  • 2.7. Diagnosis

3. Epidemiology and Patient Population

4. Key Findings

  • 4.1. Population and Forecast Parameters
  • 4.2. 7MM Total Diagnosed Prevalent Patient Population of Allergic Conjunctivitis

5. Country Wise-Epidemiology of Allergic Conjunctivitis

  • 5.1. United States
    • 5.1.1. Total Prevalent Patient Population of Allergic Conjunctivitis in the US
    • 5.1.2. Sub-type Specific Prevalence of Allergic Conjunctivitis in the US
  • 5.2. EU5 Countries
    • 5.2.1. Germany
    • 5.2.2. Total Prevalent Patient Population of Allergic Conjunctivitis in Germany
    • 5.2.3. Sub-type Specific Prevalence of Allergic Conjunctivitis in Germany
    • 5.2.4. France
    • 5.2.5. Total Prevalent Patient Population of Allergic Conjunctivitis in France
    • 5.2.6. Sub-type Specific Prevalence of Allergic Conjunctivitis in France
    • 5.2.7. Italy
    • 5.2.8. Total Prevalent Patient Population of Allergic Conjunctivitis in Italy
    • 5.2.9. Sub-type Specific Prevalence of Allergic Conjunctivitis in Italy
    • 5.2.10. Spain
    • 5.2.11. Total Prevalent Patient Population of Allergic Conjunctivitis in Spain
    • 5.2.12. Sub-type Specific Prevalence of Allergic Conjunctivitis in Spain
    • 5.2.13. United Kingdom
    • 5.2.14. Total Prevalent Patient Population of Allergic Conjunctivitis in the UK
    • 5.2.15. Sub-type Specific Prevalence of Allergic Conjunctivitis in the UK
  • 5.3. Japan
    • 5.3.1. Total Prevalent Patient Population of Allergic Conjunctivitis in Japan
    • 5.3.2. Sub-type Specific Prevalence of Allergic Conjunctivitis in Japan

6. Unmet Needs

7. Appendix

8. Report Methodology

  • 8.1. Sources Used

9. DelveInsight Capabilities

10. Disclaimer

11. About DelveInsight

List of Tables

Table 1 Characteristics of types of AC

Table 2 Risk factors for Allergic Conjunctivitis

Table 3 Clinical involvement of the ocular tissues in allergic eye disorders

Table 4 Grading of symptoms and severity (Based on ARIA Criteria)

Table 5 Total Prevalent Patient Population of Allergic Conjunctivitis in the 7MM (2016-2028)

Table 6 Total Prevalent Population of Allergic Conjunctivitis in the United States (2016-2028)

Table 7 Sub-type Specific Prevalence of Allergic Conjunctivitis in the United States (2016-2028)

Table 8 Total Prevalent Population of Allergic Conjunctivitis in Germany (2016-2028)

Table 9 Sub-type Specific Prevalence of Allergic Conjunctivitis in Germany (2016-2028)

Table 10 Total Prevalent Population of Allergic Conjunctivitis in France (2016-2028)

Table 11 Sub-type Specific Prevalence of Allergic Conjunctivitis in France (2016-2028)

Table 12 Total Prevalent Population of Allergic Conjunctivitis in Italy (2016-2028)

Table 13 Sub-type Specific Prevalence of Allergic Conjunctivitis in Italy (2016-2028)

Table 14 Total Prevalent Population of Allergic Conjunctivitis in Spain (2016-2028)

Table 15 Sub-type Specific Prevalence of Allergic Conjunctivitis in Spain (2016-2028)

Table 16 Total Prevalent Population of Allergic Conjunctivitis in the UK (2016-2028)

Table 17 Sub-type Specific Prevalence of Allergic Conjunctivitis in the United Kingdom (2016-2028)

Table 18 Total Prevalent Population of Allergic Conjunctivitis in Japan (2016-2028)

Table 19 Sub-type Specific Prevalence of Allergic Conjunctivitis in Japan (2016-2028)

List of Figures

Figure 1 Characteristics of types of AC

Figure 2 Risk factors for Allergic Conjunctivitis

Figure 3 Clinical involvement of the ocular tissues in allergic eye disorders

Figure 4 Grading of symptoms and severity (Based on ARIA Criteria)

Figure 5 Total Prevalent Patient Population of Allergic Conjunctivitis in the 7MM (2016-2028)

Figure 6 Total Prevalent Population of Allergic Conjunctivitis in the United States (2016-2028)

Figure 7 Sub-type Specific Prevalence of Allergic Conjunctivitis in the United States (2016-2028)

Figure 8 Total Prevalent Population of Allergic Conjunctivitis in Germany (2016-2028)

Figure 9 Sub-type Specific Prevalence of Allergic Conjunctivitis in Germany (2016-2028)

Figure 10 Total Prevalent Population of Allergic Conjunctivitis in France (2016-2028)

Figure 11 Sub-type Specific Prevalence of Allergic Conjunctivitis in France (2016-2028)

Figure 12 Total Prevalent Population of Allergic Conjunctivitis in Italy (2016-2028)

Figure 13 Sub-type Specific Prevalence of Allergic Conjunctivitis in Italy (2016-2028)

Figure 14 Total Prevalent Population of Allergic Conjunctivitis in Spain (2016-2028)

Figure 15 Sub-type Specific Prevalence of Allergic Conjunctivitis in Spain (2016-2028)

Figure 16 Total Prevalent Population of Allergic Conjunctivitis in the UK (2016-2028)

Figure 17 Sub-type Specific Prevalence of Allergic Conjunctivitis in the United Kingdom (2016-2028)

Figure 18 Total Prevalent Population of Allergic Conjunctivitis in Japan (2016-2028)

Figure 19 Sub-type Specific Prevalence of Allergic Conjunctivitis in Japan (2016-2028)